Harvard Apparatus Regenerative Technology annual ebitda margin
2013
2014
2015
2016
2023
2024
2025
Harvard Apparatus Regenerative Technology EBITDA Margin Growth & History (HRGN)
Harvard Apparatus Regenerative Technology's ebitda margin was −981.53% for fiscal 2025.
View full Harvard Apparatus Regenerative Technology company overviewHarvard Apparatus Regenerative Technology annual ebitda margin history
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −981.53% | +811.95 pp |
| 2024 | 2024-12-31 | −1,793.49% | +6900.69 pp |
| 2023 | 2023-12-31 | −8,694.17% | — |
| 2016 | 2016-12-31 | −14,234.15% | −4723.13 pp |
| 2015 | 2015-12-31 | −9,511.02% | +1987.91 pp |
| 2014 | 2014-12-31 | −11,498.92% | +27860.17 pp |
| 2013 | 2013-12-31 | −39,359.09% | — |
Harvard Apparatus Regenerative Technology quarterly ebitda margin
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q2.15
Q3.15
Q4.15
Q2.16
Q3.16
Q4.16
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −408.45% | +169.46 pp |
| Q1 2026 | 2026-03-31 | −710.18% | +2996.49 pp |
| Q4 2025 | 2025-12-31 | −774.89% | −246.59 pp |
| Q3 2025 | 2025-09-30 | −1,392.68% | +1756.47 pp |
| Q2 2025 | 2025-06-30 | −577.92% | +3843.51 pp |
| Q1 2025 | 2025-03-31 | −3,706.67% | −171.58 pp |
| Q4 2024 | 2024-12-31 | −528.29% | — |
| Q3 2024 | 2024-09-30 | −3,149.15% | +895.85 pp |
| Q2 2024 | 2024-06-30 | −4,421.43% | — |
| Q1 2024 | 2024-03-31 | −3,535.09% | — |
| Q3 2023 | 2023-09-30 | −4,045.00% | — |
| Q4 2016 | 2016-12-31 | −12,389.29% | +14598.21 pp |
| Q3 2016 | 2016-09-30 | −11,665.38% | −5797.82 pp |
| Q2 2016 | 2016-06-30 | −10,032.14% | −4025.29 pp |
| Q4 2015 | 2015-12-31 | −26,987.50% | −20909.72 pp |
| Q3 2015 | 2015-09-30 | −5,867.57% | +122682.43 pp |
| Q2 2015 | 2015-06-30 | −6,006.85% | +4593.15 pp |
| Q4 2014 | 2014-12-31 | −6,077.78% | +5799.49 pp |
| Q3 2014 | 2014-09-30 | −128,550.00% | — |
| Q2 2014 | 2014-06-30 | −10,600.00% | — |
| Q1 2014 | 2014-03-31 | −12,826.09% | — |
| Q4 2013 | 2013-12-31 | −11,877.27% | — |
Harvard Apparatus Regenerative Technology ebitda margin trends
Between the periods ended 2013-12-31 and 2025-12-31, Harvard Apparatus Regenerative Technology's ebitda margin increased from −39,359.09% to −981.53%, a change of +38377.56 percentage points. The latest reported quarter, Q2 2026, shows −408.45%.
About the metric
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
Calculation and source
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Harvard Apparatus Regenerative Technology source filings ↗